Effects of IFN-beta1a and IFN-beta1b treatment on the expression of cytokines, inducible NOS (NOS type II), and myelin proteins in animal model of multiple sclerosis

• Autorzy: Lubina-Dabrowska N. , Stepien A. , Sulkowski G. , Dabrowska-Bouta B. , Langfort J. , Chalimoniuk M.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

interferon beta; cytokine; inducible nitric oxide synthase; myelin protein; brain cortex; experimental autoimmune encephalomyelitis; multiple sclerosis; neurodegenerative disease

• Wydawca: -
• Czasopismo: Archivum Immunologiae et Therapiae Experimentalis
• Rocznik: 2017
• Tom: 65
• Numer: 4
• Opis fizyczny: p.325-338,fig.,ref.

Twórcy

autor

Lubina-Dabrowska N.

• Neurology Clinic, Military Institute of Medicine, Warsaw, Poland
• Department of Cellular Signalling, Mossakowski Medical Research Centre, Polish Academy of Sciences, Pawinskiego 5, 02-106 Warsaw, Poland

autor

Stepien A.

• Neurology Clinic, Military Institute of Medicine, Warsaw, Poland

autor

Sulkowski G.

• Laboratory of Pathoneurochemistry, Department of Neurochemistry, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland

autor

Dabrowska-Bouta B.

• Laboratory of Pathoneurochemistry, Department of Neurochemistry, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland

autor

Langfort J.

• Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland
• Department of Sports Training, The Jerzy Kukuczka Academy of Physical Education, Katowice, Poland

autor

Chalimoniuk M.

• Department of Cellular Signalling, Mossakowski Medical Research Centre, Polish Academy of Sciences, Pawinskiego 5, 02-106 Warsaw, Poland

Identyfikatory

DOI

10.1007/s00005-017-0458-6